Roxana Boanta

Roxana Boanta

Auto-generated profile, based on publicly available information

Roxana Boanta


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
RBRoxana Boanta
Roxana Boanta
MMMihaela Misca
Mihaela Misca
VGValentin Titus Grigorean
Valentin Titus Grigorean
VSVictor Dan Eugen Strambu
Victor Dan Eugen Strambu
IBIulian Brezean
Iulian Brezean
Background: Postoperative hypoparathyroidism remains the most frequent complication of thyroid surgery. Indocyanine green (ICG) fluorescence imaging assesses parathyroid perfusion intraoperatively, but most published series rely on liberal parathyroid autotransplantation. We assessed the feasibility, safety, and preliminary efficacy of ICG-guided in-situ parathyroid preservation under a strict no-autotransplantation policy. Methods: In this single-centre prospective cohort study at the Department of Endocrine Surgery, "C.I. Parhon" National Institute of Endocrinology (Bucharest, Romania), we enrolled in parallel two cohorts of 50 consecutive patients each between January and December 2024. The ICG cohort underwent intraoperative near-infrared fluorescence imaging with the Karl Storz IMAGE1 S™ Rubina® system; the control cohort was operated by the same surgical team during the same period when the imaging platform was not available. Allocation was determined by system availability and was effectively random with respect to clinical characteristics. Each parathyroid gland was scored on the Vidal Fortuny 0–1–2 scale. No autotransplantation was performed. The primary outcome was permanent hypoparathyroidism at 12 months, defined per the ESES/AAES/IAES 2025 consensus. Findings: Cohorts were matched for age, sex, BMI, and indication. Of 200 parathyroid glands scored, 123 (61·5%) scored 2 and 188 of 200 (94·0%) were identified. Permanent hypoparathyroidism occurred in 0 of 46 ICG patients versus 3 of 46 controls (6·5%; Fisher's exact p=0·24). The composite severe endpoint affected 2 of 46 (4·3%) ICG versus 8 of 46 (17·4%) controls (p=0·09). In the prespecified benign-disease subgroup, the composite severe endpoint occurred in 1 of 34 (2·9%) ICG versus 7 of 28 (25·0%) controls (Fisher's exact p=0·018). No ICG-related adverse events occurred. Interpretation: ICG fluorescence-guided in-situ parathyroid preservation without autotransplantation was feasible, safe, and signalled a reduction in severe hypoparathyroidism, particularly in benign thyroid disease. A randomised controlled trial is warranted.

17 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MMMihaela Misca
Mihaela Misca
RBRoxana Boanta
Roxana Boanta
SPSorin Petrea
Sorin Petrea
SASorin Aldoescu
Sorin Aldoescu
ECEDUARD LUCIAN CATRINA
EDUARD LUCIAN CATRINA
IBIulian Brezean
Iulian Brezean
Introduction: Low and ultralow colorectal anastomoses, used in the surgical treatment of lower rectal cancer, are associated with an increased risk of anastomotic fistula and local complications, especially in the context of sphincter-sparing procedures. Near-infrared/ICG fluorescence technology enables objective assessment of tissue viability and can influence intraoperative decisions by modifying the transection level or adjusting the anastomotic configuration. Clinical data and the literature suggest a more pronounced potential benefit in anastomoses located at 4–8 cm from the anal margin, where vascular reserve is limited.Methods and Results: We conducted a prospective study at our service during 2021–2025, including patients in whom the ICG/NIR intraoperative technique was used, with a predilection for colorectal tumor pathology. In 2021–2025, our department surgically treated 420 patients with colorectal cancer, of whom 70 had rectal cancer, with 27 undergoing sphincter-sparing resections and the rest undergoing abdominoperineal amputation. Indocyanine green (ICG) was used in 22 cases to evaluate the viability of colonic segments and the perfusion of anastomoses, aiming to optimize reconstructive safety. Our department’s experience indicates an upward trend in restorative procedures, but this is accompanied by an increase in morbidity due to local complications, which necessitates integrating modern perfusion assessment methods, such as ICG, into treatment algorithms.Conclusions: Preservation of the anal sphincter remains an important goal for patients and a technical and oncologic challenge for the surgeon, requiring careful selection, rigorous counseling, and standardized intraoperative evaluation of perfusion. ICG/NIR technology can be a truly helpful instrument in the surgical decision-making process, influencing the surgical strategy and the postoperative evolution of patients.